Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Minor site revision updates were applied, adding Revision: v3.3.4 and removing Revision: v3.3.3. The study details and eligibility criteria remain unchanged.
    Difference
    0.0%
    Check dated 2026-01-14T02:12:54.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page based on the provided screenshot and text. The page content appears unchanged.
    Difference
    0.1%
    Check dated 2025-12-30T13:46:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing numerous study sites (including Patras, Greece) and updated the page revision to v3.3.3. The previous separate location blocks appear to have been replaced by this consolidated listing.
    Difference
    2%
    Check dated 2025-12-23T09:24:38.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Only minor formatting/text updates observed; no changes to inclusion criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-08T20:15:16.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears on the page, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:39:30.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Publications section now notes that items are auto-filled from PubMed and shows revision v3.3.1, replacing the previous PubMed-specific wording and the v3.2.0 label. To avoid alerts from small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:19:53.000Z thumbnail image

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.